[Indications and results of immunosuppressive therapy of idiopathic thrombocytopenic purpura].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*; D013156:Splenectomy; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone
Indications et résultats de la thérapie immunosuppressive dans le purpura thrombocytopénique idiopathique.